Clinical Trials in Maryland

Showing 4381-4400 of 17,687 trials

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

NCT04076813

The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.

Myocardial Infarction

Chiesi USA, Inc.5,050 participantsStarted Oct 2019

La Jolla, California, United States • Newark, Delaware, United States • Gainesville, Florida, United States +8 more locations

Active Not RecruitingPhase 217 miles

Multi-Center Study of ManNAc for GNE Myopathy

NCT04231266

GNE myopathy is a rare genetic muscle disease characterized by progressive muscle atrophy and weakness. The disease is caused by mutations in the gene that encodes the enzyme that initiates and regulates N-acetylneuraminic acid (Neu5Ac) biosynthesis and glycan sialylation. Currently, there is no therapy available for this disease. N-Acetylmannosamine (ManNAc), an orphan drug in development for GNE myopathy, is an uncharged monosaccharide and the first committed precursor in Neu5Ac biosynthesis. In this randomized, double-blind, placebo-controlled trial the efficacy and long-term safety of ManNAc will be evaluated in subjects with GNE myopathy.

GNE Myopathy

Leadiant Biosciences, Inc.54 participantsStarted Apr 2022

Los Angeles, California, United States • Iowa City, Iowa, United States • Kansas City, Kansas, United States +7 more locations

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

Multi-Center Study of ManNAc for GNE Myopathy

Find Trials by Condition in Maryland

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

Anti-Inflammatory Effects of Time-Restricted Feeding

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)

Reproductive Health Program in Patients With Cancer

AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies.

AVID100 in Advanced Epithelial Carcinomas

A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)

Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

An Evaluation of the Safety of CSF-1 in Presbyopic Subjects

Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Natural History Study of Synucleinopathies

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy